In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

All About Clinical Trials

Online training course by the ESC Working Group on Cardiovascular Pharmacotherapy

10/12/2020 08:30 11/12/2020 12:30 Europe/Paris All About Clinical Trials

Access event page

ESC Working Group on Cardiovascular Pharmacotherapy contact@escardio.org DD/MM/YYYY
Pharmacology and Pharmacotherapy
Online
event

Summary

This event will provide a deep insight into the long journey which brings pharmacological compounds from bench to bedside, i.e. from trial design for testing new drugs (generation of evidence and its critical appraisal) to implementation of pharmacological treatments for daily use in science and patient care.

Learning objectives

Reduction of cardiovascular disease burden by pharmacotherapy is a multistep approach, which requires:

  • the identification of new potential drugs;
  • testing new potential pharmacological compounds in a trial setting;
  • regulatory approval;
  • implementation of therapies in clinical practice.

The specific aim of the All About Clinical Trials course is to improve competency and confidence in:

  • Designing and planning successful clinical trials;
  • Evaluating and following the correct processes and regulatory procedures (GCP certificate included);
  • Effectively analysing and interpreting trial data through highly interactive workshops.

Conference scientific committee

  • Prof. Sven Wassmann, Germany
  • Prof. Gianluigi Savarese, Sweden

Scientific programme

This programme is subject to change.

Session 1. How to design and run a clinical trial

  • An overview of the different aspects of clinical trials
  • Planning and running a clinical trial: site perspective
  • Traditional versus novel trial designing

Session 2. Regulatory aspects

  • Requirements from regulatory agencies and post-marketing surveillance

Session 3. Registries and registry-based trials

  • Registry-based trials in ischemic heart disease
  • Registry-based trials in heart failure

Session 4. Issues in clinical trials

  • Challenges of running clinical trials in a pandemic

Workshops

  • Workshop 1 - Statistical issues in clinical trials (Limited seats) 
    Randomised controlled trials
  • Workshop 2 - Statistical issues in clinical trials (Limited seats) 
    Observational studies
  • Workshop 3 - Statistical issues in clinical trials (Limited seats) 
    Systematic reviews and meta-analyses
  • Workshop 4 - How to interprest clinical trial data
    Examples from clinical trials

Resources from past Courses 

All About Clinical Trials 2019: Access slides 

 

All About Clinical Trials 2020 Webcasts

Feedback from previous courses

Since its launch in 2015, more than 350 participants have taken this course in clinical trials. 

  • 95% of participants would recommend the course to their peers
  • 65% attend the course to learn about methodology for designing and running a clinical trial
  • 54% attend the course to learn statistical approaches

Testimonial

“The course allowed me not only to gain a deeper insight into the complex process of organising clinical trials, but it also offered an opportunity to discuss specific methodological pitfalls and interpret the results in cooperation with professionals who represent the highest level of expertise in the field. I highly recommend the course both to experienced investigators and to young researchers, since apart from the conventional aspects of clinical trials methodology; it also presented a novel approach to run the research efficiently and successfully.”
Aleksandra Gąsecka, Poland